Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Chlebowski

Showing results (331-340 of 379) with videos related to

Pageof 38
Sort By:
International Journal of Cancer|August 24, 2017
Methodological considerations for disentangling a risk factor's influence on disease incidence versus postdiagnosis survival: The example of obesity and breast and colorectal cancer mortality in the Women's Health InitiativeElizabeth M Cespedes Feliciano, Ross L Prentice, Aaron K Aragaki, et al.
International Journal of Cancer|September 6, 2018
Estrogen metabolism in menopausal hormone users in the women's health initiative observational study: Does it differ between estrogen plus progestin and estrogen alone?Roni T Falk, JoAnn E Manson, Vanessa M Barnabei, et al.
Cancer|January 21, 2021
Metabolic syndrome risk components and mortality after triple-negative breast cancer diagnosis in postmenopausal women in the Women's Health InitiativeYuan Yuan, Kathy Pan, Joanne Mortimer, et al.
Nutrition and Cancer|July 22, 2011
The effect of calcium plus vitamin D on risk for invasive cancer: results of the Women's Health Initiative (WHI) calcium plus vitamin D randomized clinical trialRobert L Brunner, Jean Wactawski-Wende, Bette J Caan, et al.
Lancet (London, England)|September 22, 2009
Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trialRowan T Chlebowski, Ann G Schwartz, Heather Wakelee, et al.
Menopause (New York, N.Y.)|June 9, 2026
Low-fat dietary pattern and dementia mortality: a secondary analysis of the Women's Health Initiative dietary modification randomized clinical trial with long-term follow-upRowan T Chlebowski, Stephen Rapp, Aaron K Aragaki, et al.
Annals of Internal Medicine|July 7, 2025
Development and Validation of Body Mass Index-Specific Waist Circumference Thresholds in Postmenopausal Women : A Prospective Cohort StudyAaron K Aragaki, JoAnn E Manson, Erin S LeBlanc, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 8, 2020
Dietary Modification and Breast Cancer Mortality: Long-Term Follow-Up of the Women's Health Initiative Randomized TrialRowan T Chlebowski, Aaron K Aragaki, Garnet L Anderson, et al.
Journal of the National Cancer Institute|June 12, 2019
Insulin Resistance and Cancer-Specific and All-Cause Mortality in Postmenopausal Women: The Women's Health InitiativeKathy Pan, Rebecca A Nelson, Jean Wactawski-Wende, et al.
Menopause (New York, N.Y.)|August 1, 2023
Menopausal hormone therapy and change in physical activity in the Women's Health Initiative hormone therapy clinical trialsRita Peila, Xiaonan Xue, Michael J LaMonte, et al.
Pageof 38

Showing results (331-340 of 379) with videos related to

Sort By:
Pageof 38
International Journal of Cancer|August 24, 2017
Methodological considerations for disentangling a risk factor's influence on disease incidence versus postdiagnosis survival: The example of obesity and breast and colorectal cancer mortality in the Women's Health InitiativeElizabeth M Cespedes Feliciano, Ross L Prentice, Aaron K Aragaki, et al.
International Journal of Cancer|September 6, 2018
Estrogen metabolism in menopausal hormone users in the women's health initiative observational study: Does it differ between estrogen plus progestin and estrogen alone?Roni T Falk, JoAnn E Manson, Vanessa M Barnabei, et al.
Cancer|January 21, 2021
Metabolic syndrome risk components and mortality after triple-negative breast cancer diagnosis in postmenopausal women in the Women's Health InitiativeYuan Yuan, Kathy Pan, Joanne Mortimer, et al.
Nutrition and Cancer|July 22, 2011
The effect of calcium plus vitamin D on risk for invasive cancer: results of the Women's Health Initiative (WHI) calcium plus vitamin D randomized clinical trialRobert L Brunner, Jean Wactawski-Wende, Bette J Caan, et al.
Lancet (London, England)|September 22, 2009
Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trialRowan T Chlebowski, Ann G Schwartz, Heather Wakelee, et al.
Menopause (New York, N.Y.)|June 9, 2026
Low-fat dietary pattern and dementia mortality: a secondary analysis of the Women's Health Initiative dietary modification randomized clinical trial with long-term follow-upRowan T Chlebowski, Stephen Rapp, Aaron K Aragaki, et al.
Annals of Internal Medicine|July 7, 2025
Development and Validation of Body Mass Index-Specific Waist Circumference Thresholds in Postmenopausal Women : A Prospective Cohort StudyAaron K Aragaki, JoAnn E Manson, Erin S LeBlanc, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 8, 2020
Dietary Modification and Breast Cancer Mortality: Long-Term Follow-Up of the Women's Health Initiative Randomized TrialRowan T Chlebowski, Aaron K Aragaki, Garnet L Anderson, et al.
Journal of the National Cancer Institute|June 12, 2019
Insulin Resistance and Cancer-Specific and All-Cause Mortality in Postmenopausal Women: The Women's Health InitiativeKathy Pan, Rebecca A Nelson, Jean Wactawski-Wende, et al.
Menopause (New York, N.Y.)|August 1, 2023
Menopausal hormone therapy and change in physical activity in the Women's Health Initiative hormone therapy clinical trialsRita Peila, Xiaonan Xue, Michael J LaMonte, et al.
Pageof 38